Brenda Vega-Chimal

Mexicali, BCN, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The transition from preclinical to clinical obesity: the importance of a borderline stage.

The transition from preclinical to clinical obesity: the importance of a borderline stage.

Journal: Clinical science (London, England : 1979)

Published: April 21, 2025

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.

Journal: Scientific reports

Published: February 28, 2025

Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Journal: International journal of molecular sciences

Published: February 23, 2025

Potential Ligands to Resistin Against Prostate Cancer, Evaluated by Molecular Docking and In Vitro Assays to Develop an Anticancer Drug.

Potential Ligands to Resistin Against Prostate Cancer, Evaluated by Molecular Docking and In Vitro Assays to Develop an Anticancer Drug.

Journal: Chemistry & biodiversity

Published: January 15, 2025

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Journal: Pharmaceutics

Published: July 07, 2024

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.

Journal: Bioscience reports

Published: April 15, 2024

Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.

Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.

Journal: International journal of molecular and cellular medicine

Published: January 01, 2024

Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells.

Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells.

Journal: Biomedicines

Published: December 23, 2023

Translation initiation and its relationship with metabolic mechanisms in cancer development, progression and chemoresistance.

Translation initiation and its relationship with metabolic mechanisms in cancer development, progression and chemoresistance.

Journal: Advances in protein chemistry and structural biology

Published: September 10, 2022

eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.

eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.

Journal: Cells

Published: July 28, 2022

LDL Promotes Disorders in β-Cell Cholesterol Metabolism, Implications on Insulin Cellular Communication Mediated by EVs.

LDL Promotes Disorders in β-Cell Cholesterol Metabolism, Implications on Insulin Cellular Communication Mediated by EVs.

Journal: Metabolites

Published: July 18, 2022

Recent Advances by In Silico and In Vitro Studies of Amyloid-β 1-42 Fibril Depicted a S-Shape Conformation.

Recent Advances by In Silico and In Vitro Studies of Amyloid-β 1-42 Fibril Depicted a S-Shape Conformation.

Journal: International journal of molecular sciences

Published: July 14, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026